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Abstract 
Introduction:  To study the in vitro antimicrobial 
activity of garlic (Allium Sativum) against clinical 
isolates of Vibrio Cholerae 
Methods: Thirty three clinical isolates of V. 
cholerae were evaluated for their susceptibility to 
aqueous extract of Pakistani and Chinese garlic. 
ATCC strain of P. aeruginosa (ATCC 27853) was 
used as the standard control strain. The cloves were 
peeled and blended (50 gm) in 90 ml of distilled 
water in separate blenders. The extracts were 
sterilized by gamma radiation. Aqueous extracts of 
Pakistani and Chinese garlic were tested in 
triplicate. Quantitative analysis of Pakistani and 
Chinese garlic aqueous extracts was done. As the 
extracts of both types of Pakistani and Chinese garlic 
exhibited inhibitory effect against test strain of V. 
cholerae, aqueous extracts were further evaluated in 
agar dilution assay to determine MIC against thirty 
three clinical isolates of V. cholerae and one ATCC 
reference strain.  
Results: The zones of inhibition measured by using 
agar well diffusion assay were 28.12 mm and 32.14 
mm for Pakistani and Chinese garlic aqueous 
extracts respectively. All the isolates were inhibited 
at concentration of 8.66 mg/mL by Chinese garlic and 
at 10 mg/mL by Pakistani garlic aqueous extract. 
Conclusion: Natural sources, like garlic extracts ,  
may be an effective alternative, to resistant strains of 
vibrio cholera. 
Key Words: In Vitro , Antimicrobial Activity , 
Garlic, Allium Sativum,  Vibrio Cholerae 
Introduction 
Cholera is an acute enteric infection which in its most 
severe form causes acute watery diarrhea that can lead 
to death within few hours due to dehydration. The 
first line antibiotics to treat cholera are tetracycline, 
ampicillin, nalixic acid, furazolidone and co-
trimoxazole. Since 1979 their general usefulness has 
reduced with the emergence of resistance to these 
antibiotics. Transmission to humans is by food or 
water.  1,2   
Between 1995 and 2004, the World Health 
Organization (WHO) reported 100,000 to 300,000 
cholera cases. Due to poor surveillance systems and 
frequent under reporting, WHO estimates that 
approximately 99% of cholera cases go unreported. 
WHO estimates that actual case rates approach 3 to 5 
million with more than 120,000 of those cases leading 
to mortality. 3 In 2010, 317 534 cholera cases and 7543 
deaths due to cholera were reported globally which 
represents 52% increase as compared to 2009.4  
Until 1993, cholera was solely associated with V. 
cholerae strains of the O1 serogroup. All other strains 
that were identified as V. cholerae on the basis of 
biochemical tests, but that did not agglutinate with 
“O” antiserum were referred to as non-O1 V. cholera. 
However, in 1993, a new epidemic strain caused 
cholera like disease in Bangladesh which did not 
agglutinate with O1 and non O1 antisera. This new 
strain was given the designation of O 139 Bengal after 
the area from where it was first isolated.5  After the 
recognition of epidemic strain 0139, the term non O1 
and non 139 is used to include all other serogroups of 
V.cholerae except O1 and O139. The non O1 and non 
O139 are occasionally isolated from cases of diarrhoea, 
from a variety of extraintestinal infections, wounds, 
sputum, ear, urine, and cerebrospinal fluid. 6,7 The O1 
serogroup has two biotypes, classical and El Tor. On 
the basis of antigenic factors, O1 serogroup is further 
differentiated into two major serotypes Ogawa and 
Inaba. Strains of the Ogawa serotype express the A 
and B antigens, while Inaba strains express only the A 
and C antigens. A third serotype, Hikojima, expresses 
all three antigens but is rare.8,9  
Antimicrobial therapy decreases the volume of fluid 
loss, duration of illness, and duration of excretion. The 
choice of antibiotics for treating cholera is primarily 
determined by the patterns of bacterial resistance and 
antibiotic toxicity. Tetracyclines and its derivatives 
have been the antibiotics of choice for treatment of 
cholera in adults but not in children due to staining of 
teeth.10 Azithromycin, a derivative of erythromycin 
has been effective for cholera in children. Watery 
stools stop within two days of giving azithromycin in 
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more than 70% of patients and V. cholerae is 
eliminated from stool within two days from the start of 
treatment in almost 80% of people.11  
Multiple studies denote that resistance is progressively 
increasing in developing countries. In 1977, Tanzania 
was the first country to report multidrug resistant El 
Tor V.  cholerae, followed by several such reports from 
all over the world.12  India has reported a sudden 
upsurge in tetracycline, furazolidone and 
trimethoprim/sulfamethoxazole resistance among V. 
cholerae isolates.  
Throughout human history, traditional herbal 
medicine has played a vital in the treatment of various 
diseases. Although on the bases of historical evidences 
several plant species had been used to cure different 
infectious diseases but there are limited scientific 
publications supporting these evidences.13  
Garlic is nicknamed as Russian penicillin due to its 
widespread use as a topical and systemic antimicrobial 
agent. Its botanical name is Allium sativum, belongs to 
family Liliaceae, which also includes onions, shallots, 
leeks, chives and scallions.  From centuries garlic have 
been extensively used in different civilizations to cure 
infectious diseases.   
 
Material and Methods 
Thirty three clinical isolates of V. cholerae were 
evaluated for their susceptibility to aqueous extract of 
Pakistani and Chinese garlic. ATCC strain of P. 
aeruginosa (ATCC 27853) was used as the standard 
control strain.Antimicrobial susceptibility of the 
strains to various antibiotics was tested by Kirby-
Bauer discs diffusion method according to Clinical and 
Laboratory Standards Institute (CLSI) 
protocols.Aqueous extracts of both varieties of 
Pakistani and Chinese garlic were prepared. The 
cloves were peeled and blended (50 gm) in 90 ml of 
distilled water in separate blenders. The extracts were 
centrifuged at 5000 rpm for twenty minutes and 
squeezed through sterile muslin cloth to remove 
insoluble particles. Additional distilled water was 
added to each extract to make it exactly 100 mL by 
volume. The extracts were sterilized by gamma 
radiation at 10 kilo grays. After subtracting the weight 
of insoluble material from the original weight of 
cloves, the final concentrations of extracts were 
determined to be 133 mg/mL. Serial two fold dilutions 
were prepared for qualitative analysis of 
extract.Aqueous extracts of Pakistani and Chinese 
garlic were tested in triplicate by adding 120 µL in 
each well with the same allocated number on the assay 
plate with serial two fold diluted concentrations i.e 
133, 66.5, 33.25, 16.62, 8.31, 4.15, 2.75, 1.37 mg/mL. An 
equal quantity of normal saline was filled as a negative 
control. After application of extracts and controls, the 
plates were incubated for 18-24 hours at 37˚C. The 
diameter of the clear zones was measured in mm with 
digital calipers (Sylac Fowler ultra-call II). 
Quantitative analysis of Pakistani and Chinese garlic 
aqueous extracts was done by by agar dilution 
assay.As the extracts of both types of Pakistani and 
Chinese garlic exhibited inhibitory effect against test 
strain of V. cholerae, aqueous extracts were further 
evaluated in agar dilution assay to determine MIC 
against thirty three clinical isolates of V. cholerae and 
one ATCC reference strain. This assay is more 
sensitive and provides quantitative results which are 
closer to clinical scenario.Following concentrations of 
garlic extracts tested were as : 2.0, 3.3, 4.6, 6.0, 7.3, 8.6, 
10.0, 11.3, 12.6, 14.0, and 15.33 mg/ml. (for 
calculations of garlic concentrations from stock 
solution of garlic extract 
Results 
With the method of well diffusion and in agar dilution 
assay, both the garlic extracts exhibited antibacterial 
activity against the strains of V. cholerae (n=33). 
However aqueous extract of Chinese garlic exhibited 
better antimicrobial activity than that of Pakistani 
garlic against V. cholerae. An examination of the zones 
of inhibition reveals that the inhibitory activity is 
linear function of concentration  
Table 1:  Zones of inhibition of aqueous garlic 
extracts (A. sativum) against V. cholerae (UHS 1) 
by agar well diffusion method. 
Concentrations  
of extracts 
mg/mL 
 
Zone of inhibition (mm) 
C.G.A.E 
Mean +  S.D 
P.G.A.E 
Mean +  S.D 
133 32.14+0.12 28.12+0.05 
66.5 25.71+0.09 24.43+0.11 
33.25 23.78+0.07 22.50+0.06 
16.62 20.56+0.15 19.56+0.12 
8.31 18.17+0.17 16.54+0.13 
4.15 14.57+0.11 12.15+0.06 
2.75 0 + 0 0 + 0 
1.37 0 + 0 0 + 0 
              Phenol 6%           34.12+0.13 
             Normal saline 0 + 0 
C.G.A.E=Chinese garlic aqueous extract, P.G.A.E= Pakistani 
garlic aqueous extract;S.D = Standard deviation. 
 
Qualitative assay  shows that C.G.A.E exhibited 32.14 
+ 0.10 mm zone of inhibition at highest concentration 
of 133 mg/mL and 14.57+ 0.13 mm at lowest 
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concentration of 4.15mg/mL. Whereas P.G.A.E 
exhibited 28.12+ 0.11mm zone of inhibition at 
concentration of 133 mg/mL and 14.15 + 0.5 mm at 
lowest concentration of 4.15 mg/mL. The positive 
control 6% phenol (w/v) exhibited 34.12 + 0.62 mm 
zone against V. cholerae, whereas, negative control 
normal saline showed no zone of inhibition(Table 1;Fig 
1).  
 
Table 2: Minimum inhibitory concentration of 
Chinese garlic aqueous extract against 33 strains 
of V. cholerae 
MIC of Aqueous extract of Chinese garlic against V.  cholerae 
Concentration 
of extract 
(mg/mL) 
2.0 3.33 4.66 6.0 7.33 8.66 10.0 11.33 12.66 14.0 15.3 
No of isolates 
inhibited 
0 0 0 7 23 33 33 33 33 33 33 
% of isolates 
inhibited 
0% 0% 0% 30% 69% 100% 100% 100% 100% 100% 100% 
  
 
Figure 1: MIC of Chinese garlic extract  
 
Table 3: Minimum inhibitory concentration of 
aqueous extract of Pakistani garlic against 33 
strains of V. cholerae 
MIC of Aqueous extract of Pakistani garlic against V.  cholerae 
Concentrati
on of 
extract 
(mg/mL) 
2.0 3.33 4.6 6.0 7.3 8.66 10.0 11.33 12.66 14.0 15.3 
No of 
isolates 
inhibited 
0 0 0 0 09 22 33 33 33 33 33 
% of 
isolates 
inhibited 
0% 0% 0% 0% 39% 66% 
100
% 
100% 100% 
100
% 
100
% 
In quantitative analysis of both extracts was done by in 
agar dilution assay. C.G.A.E inhibited seven out of 
thirty three clinical isolates of V. cholerae at M.I.C of 
6.00 mg/mL, twenty three isolates at M.I.C of 7.33  
 
Figure 2: MIC of Pakistani garlic extract 
 
mg/mL, and all thirty three isolates at M.I.C of 8.66 
mg/mL (Table 2).  P.G.A.E inhibited nine strains at 
M.I.C of 7.33 mg/mL and all thirty three strains at 
M.I.C of 10 mg/mL. P. aeruginosa was inhibited at 
8.66 mg/mL (Table 3;Fig 2). Statistically significant 
difference was observed in the mean M.I.C of aqueous 
extracts of  Chinese and Pakistani garlic (table 4;Fig 3).  
 Table 4: MIC range of aqueous extracts of 
Pakistani and Chinese garlic against V. cholerae 
 
Extract 
Type 
Concentration 
Range 
 (mg / mL) 
MIC50 MIC90 MIC100 
C.G.A.E 6.00-8.66 7.33 8.66 8.66 
P.G.A.E 7.33-10.0 8.66 10.0 10.0 
P.G.A.E = Pakistani garlic aqueous extract C.G.A.E = 
Chinese garlic aqueous extract;MIC= Minimum inhibitory 
concentration, in mg/mL. 
 
C.G.A.E= Chinese garlic aqueous extract P.G.A.E= Pakistani 
garlic aqueous extract 
Figure 3: MIC range of aqueous extract of Pakistani 
and Chinese garlic against vibrio cholerae 
 
Discussion 
With the emergence of antibiotic-resistant bacteria it is 
justified to explore new sources of natural products 
having antimicrobial activity. The edible plants have 
been proven to be harmless and economical and garlic 
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is known to have cure for a variety of bacterial, viral, 
parasitic and fungal diseases. Various plant extracts 
have been investigated for their antibacterial activity 
against V. cholerae including Camellia sinensis (black 
tea), Citrus limonium (Lemon), Malus sativa (Apple), 
Cydonia oblonga (membrilo), Persea gratissima 
(avocado), Lepechinia caulescens, Punica granatum 
(pomegranate), Allium cepa (onion), Allium 
ampeloprasum (elephant garlic).14 In the present 
study, a statistically significant inhibitory effect of 
aqueous extract of Pakistani and Chinese garlic against 
V. cholerae isolates was observed. It is clear from our 
results that the Chinese garlic has somewhat better 
antibacterial activity than the Pakistani garlic. The 
aqueous extract of Chinese garlic inhibited all the 
thirty three strains of V. cholerae at concentration 
range from 6.00 to 8.66 mg/mL while that of Pakistani 
garlic had MIC of 7.33 to 10 mg/mL. This antibacterial 
effect of garlic extract is probably due to the presence 
of sulfur containing compounds like thiosulfinates; 
alliin being the most abundant thiosulfinate found in 
the intact garlic bulb. When the garlic bulb is crushed, 
the enzyme alliinase is released from its vacuoles 
which acts upon the substrate alliin and convert it into 
allicin.15  Previous studies with pure allicin have 
shown that it has inhibitory effects on a wide range of 
bacteria.16, 17  A possible explanation of this difference 
in the MIC of Pakistani and Chinese garlic aqueous 
extracts may be the variable quantity of active 
ingredients present in the two varieties of garlic. It has 
also been reported that the concentration of allicin was 
twice as much in Chinese garlic compared to garlic 
cultivated in Europe and India. However, nobody so 
far has commented on the constituents of Pakistani 
garlic.  Another factor that might contribute to this 
difference in MIC could be the pH and temperature 
variations between different steps in the study. Cellini 
et al., 1996 observed antibacterial activity diminution 
during room temperature and attributed it to the 
allicin instability and its transformation with time into 
more stable components: polysulfides and 
thiosulphonates.23  
Different studies have shown that various garlic 
preparations also exhibited  different spectrum of 
antibacterial activity against both Gram-positive and 
Gram-negative bacteria including species of klebsiella, 
proteus, escherichia, salmonella, staphylococcus, 
streptococcus, bacillus, and clostridium.18  Even acid-
fast bacteria such as Mycobacterium tuberculosis are 
sensitive to garlic.19   In another in vitro study 
conducted by Pongsak et al in Thiland, Elephant garlic 
oil (Allium ampeloprasum) was found to have MIC 
range from 3.13 to 25 µg/mL against fifteen clinical 
isolates of V. cholerae. 14 In our study, the MIC values 
of Pakistani and Chinese garlic aqueous extracts fall in 
the range of 6 mg/mL to 10 mg/mL. The possible 
reason for this gross difference in the MIC range may 
be due to:  (a) oil and not the aqueous extract used in 
the study; oil was extracted directly from the elephant 
garlic bulb whereas we used 13.3% w/v of aqueous 
extract and not the oil ( b) elephant garlic is not the 
true garlic as Pakistani and Chinese garlic but a mere 
variant of leek; the two have different ingredients (c) 
Pongsak et al used bacterial suspension at 104 
CFU/mL in BHI broth whereas we carried out our 
study at 108 CFU/mL  with the in agar dilution 
technique. No other comparison can be discussed as 
there is no evidence of study on this subject. 
Our results, however, are consistent with Srinivasan et 
al.,who investigated the activity of aqueous extract of 
garlic against various pathogens at 108 CFU/mL at 
different temperature and pH.  20 The MIC of the 
extract varied from 7 to 21mg/mL for Gram negative 
bacteria while it was 6 to 11mg/ml for Gram positive 
bacteria. The Gram positive organism B. subtillis was 
comparatively more sensitive than other bacteria 
tested. This may be due to the lipid content of the 
membranes of the different groups of the 
microorganisms and the permeability of allicin and 
other garlic constituents. 
Study by Onyeagba et al , showed  no activity of 
aqueous extract has been reported against organisms 
other than the vibrio. 21 The reason for this 
nonbacterial activity was because the aqueous extract 
had been boiled by the researcher meaning thereby 
that before use boiling destroys antibacterial activity. 
Tsao et al. reported antibacterial activity  of  garlic 
against Staphylococcus aureus, , Streptococcus 
haematyticus, Streptococcus viridians, Klebsiella 
pneumoniae, Escherichia coli, Proteus vulgaris, 
Salmonella enteritidis, Bacillus subtilis, B. pumitus, B. 
mycoides, B. megaterium, B. thuringiensis, Sarcina 
lutea, and Serratia marcescens and he had used 
aqueous extract without boiling as we did in our 
study. 22 
 Cellini et al has demonstrated dose-dependent 
antimicrobial activity of garlic extract against three 
different reference strains of H. pylori at 
concentrations of 2-5 mg per ml. 23 However, heat 
treatment of the extracts reduced the inhibitory or 
bactericidal activity against H. pylori. Garlic also 
exhibited synergistic effects against H. pylori when 
given along with a proton pump-inhibitor 
(omeprazole). 
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Conclusion 
Both Chinese and Pakistani garlic aqueous extract 
have antibacterial activity against V. cholerae. The lack 
of standardization in different techniques used by 
various scientist leads to gross variation in results. A 
standardized methodology is thus needed. 
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